During the Heart Rhythm Society's Scientific Session in Chicago, our researchers presented on research topics, including risk stratification for atrial fibrillation patients, options for stroke prevention, and improving ablation techniques. You can gain a better understanding of research areas from our new releases, videos, posts and abstracts, listed below. 


Abstract List

Our team presented or contributed to the following abstracts presented at the 2017 Heart Rhythm Society Scientific Session in Chicago:

  1. A Predictive Model for Stratifying Survival and Recurrence Risk in Patients Undergoing Ventricular Tachycardia Ablation.
  2. Real-World Event Rates After Ablation or Anti-Arrhythmic Drugs for AF Management.
  3. Programmed Stimulation Predicts Arrhythmia-Free Survival Following Catheter Ablation of Non-Ischemic Ventricular Tachycardia: An IVTCC Collaborative Study.
  4. Relations Between Selected Circulating microRNAs and Atrial Fibrillation Incidence and Severity
  5. A Novel Score Predicts Recurrence of Ventricular Tachycardia after Ablation: An Analysis from the International VT Ablation Center Collaborative Group
  6. Relations Between Selected Circulating microRNAs and Atrial Fibrillation Incidence and Severity
  7. Outcomes of Catheter Ablation of Ventricular Tachycardia by Etiology in non-ischemic Heart Disease
  8. Successful Ventricular Tachycardia Ablation in the Elderly Continues to Offer Survival Benefit - An IVTCC Registry Analysis
  9. Enhanced Risk Stratification with CHA2DS2-VASc Using the Intermountain Mortality Risk Score for Stroke/Mortality and for Major Bleeding among Atrial Fibrillation Patients
  10. Spontaneous Atrial Fibrillation in Cardiac-Specific Overexpression of TGF-β Induced Atrial Myopathy with Endurance Exercise
  11. Hemodynamic Support in Catheter Ablation for Ventricular Tachycardia: An International VT Ablation Center Collaborative Group study
  12. Dementia Rates Increase With Delays In Initiation of Anticoagulation Treatment for Atrial Fibrillation
  13. Cost of AF Management After Ablation or AADs
  14. Use of the Intermountain Mortality Risk Scores and CHA2DS2-VASc for Dementia Risk Stratification among Atrial Fibrillation Patients
  15. Long-term Aspirin Does Not Lower Risk of Stroke and Increases Bleeding Risk in Low Risk Atrial Fibrillation Ablation Patients

YouTube Video Playlist

Videos from Intermountain Medical Center Heart Institute's Researchers at HRS 2017.